FIGURE 3.

Disease‐free survival in key patient subgroups of the Japanese PD‐L1 TC ≥1% stage II–IIIA population. Forest plots of disease‐free survival in patient subgroups of the Japanese stage II–IIIA population with PD‐L1 expression on ≥1% of TC. ALK, anaplastic lymphoma kinase; BSC, best supportive care; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status; EGFR, epidermal growth factor receptor; NR, not reached; OS, overall survival; PD‐L1, programmed death‐ligand 1; TC, tumor cells. ^aPer electronic case report form